These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23061314)

  • 1. Clinical practice with antidementia drugs in a geriatric clinic.
    Rungsanpanya T; Muangpaisan W; Praditsuwan R
    J Med Assoc Thai; 2012 Aug; 95(8):1081-9. PubMed ID: 23061314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication adherence in patients with dementia: an Austrian cohort study.
    Haider B; Schmidt R; Schweiger C; Forstner T; Labek A; Lampl C
    Alzheimer Dis Assoc Disord; 2014; 28(2):128-33. PubMed ID: 24113561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany.
    Hoffmann F; van den Bussche H; Glaeske G; Kaduszkiewicz H
    Int Clin Psychopharmacol; 2010 Jan; 25(1):29-36. PubMed ID: 19934763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy.
    Hartmann S; Möbius HJ
    Int Clin Psychopharmacol; 2003 Mar; 18(2):81-5. PubMed ID: 12598818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.
    Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia.
    Wong CL; Bansback N; Lee PE; Anis AH
    Can J Neurol Sci; 2009 Nov; 36(6):735-9. PubMed ID: 19960752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.
    van den Bussche H; Kaduszkiewicz H; Koller D; Eisele M; Steinmann S; Glaeske G; Wiese B
    Int Clin Psychopharmacol; 2011 Jul; 26(4):225-31. PubMed ID: 21394033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.
    Inglis F
    Int J Clin Pract Suppl; 2002 Jun; (127):45-63. PubMed ID: 12139367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of Antidementia Drugs and Antipsychotics for Elderly Patients in Japan: A Descriptive Study Using Pharmacy Prescription Data.
    Tsukada T; Sato I; Matsuoka N; Imai T; Doi Y; Arai M; Fujii Y; Matsunaga T; Kawakami K
    J Geriatr Psychiatry Neurol; 2018 Jul; 31(4):194-202. PubMed ID: 30016896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use.
    Wübbeler M; Wucherer D; Hertel J; Michalowsky B; Heinrich S; Meyer S; Schaefer-Walkmann S; Hoffmann W; Thyrian JR
    BMC Health Serv Res; 2015 May; 15():205. PubMed ID: 25998147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Education and use of dementia drugs: a register-based study of over 600,000 older people.
    Johnell K; Weitoft GR; Fastbom J
    Dement Geriatr Cogn Disord; 2008; 25(1):54-9. PubMed ID: 18037814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidementia drug treatment in people screened positive for dementia in primary care.
    Wucherer D; Eichler T; Kilimann I; Hertel J; Michalowsky B; Thyrian JR; Teipel S; Hoffmann W
    J Alzheimers Dis; 2015; 44(3):1015-21. PubMed ID: 25391382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities.
    Barthold D; Joyce G; Ferido P; Drabo EF; Marcum ZA; Gray SL; Zissimopoulos J
    J Alzheimers Dis; 2020; 76(2):579-589. PubMed ID: 32538845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of antidementia drugs in human plasma for therapeutic drug monitoring.
    Noetzli M; Choong E; Ansermot N; Eap CB
    Ther Drug Monit; 2011 Apr; 33(2):227-38. PubMed ID: 21383648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.